This review aims to provide an integrative conceptual framework on kidney cell- and context-specific roles of TGF-β, discuss the remaining challenges in therapeutic targeting of the signaling pathway, and provide a perspective on alternative approaches and opportunities in TGF-β therapy for kidney disease and fibrosis. Here, TGFB1 is linked to kidney disorder.